Miami Cancer Institute, part of Baptist Health South Florida, announced it will host the Fifth Annual Global Summit on Immunotherapies for Hematologic Malignancies, to be held March 8-9, 2024, at the JW Marriott Hotel in Brickell, Miami, Fla. Presenters at the summit will share updates on recent advances in the treatment of leukemia and myeloma, targeted therapies for acute myeloid leukemia, CAR-T cell therapies, as well as new approaches to treating lymphomas. In addition, there will be special presentations on unmet needs in Latin America and the role of haploidentical transplants.
“Our high-profile speakers at the 2024 summit represent a wide variety of leading-edge expertise in immunotherapies and hematologic malignancies. Those attending the two-day summit will learn about the latest research and treatment options in the field,” said Guenther Koehne M.D., Ph.D., summit founder, deputy director of Miami Cancer Institute and chief of blood and marrow transplant and hematologic oncology. “I am very pleased to bring world-class experts to our region, benefitting healthcare and specifically oncology professionals in our region and beyond.”
This educational summit is intended for hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, oncology and hematology nurses, laboratory personnel, pharmacists, and other allied health care team members interested in the treatment of patients with hematologic malignancies. Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians. Participants of the Precision Medicine Symposium will be able to claim CME credits when attending the symposium.
Those interested in attending the symposium can register at https://cmeonline.baptisthealth.net/immunotherapy-symposium.
For updates about Miami Cancer Institute’s Fifth Annual Global Summit on Immunotherapies for Hematologic Malignancies, follow Miami Cancer Institute on Twitter at @MiamiCancerInst.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit https://cancer.baptisthealth.net/miami-cancer-institute.
Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.
